Related Experiment Video
Updated: May 23, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
Newborn screening in Zhejiang, China
Riziwanguli Maitusong1, Rukeya Japaer, Zheng-yan Zhao
1Department of Neonatal Screening, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Newborn screening in Zhejiang from 1999-2009 identified over 2,400 cases of congenital hypothyroidism (CH) and phenylketonuria (PKU). Early detection and treatment prevented intellectual disability and physical impairment in thousands of infants.
Area of Science:
- Public Health
- Genetics
- Pediatrics
Background:
- Newborn screening (NBS) programs are crucial for early detection of genetic disorders.
- Zhejiang province initiated its NBS program in 1999.
Purpose of the Study:
- To analyze the status and outcomes of NBS in Zhejiang from 1999 to 2009.
- To determine the incidence of congenital hypothyroidism (CH) and phenylketonuria (PKU) in the screened population.
Main Methods:
- Heel-prick blood samples collected 72 hours post-birth.
- Laboratory testing for CH (thyroid-stimulating hormone) and PKU (phenylalanine).
- Dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) utilized for detection.
Main Results:
- Over 3.8 million newborns were screened between 1999 and 2009.
- 2,309 cases of CH (incidence 1:1678) and 155 cases of PKU (incidence 1:25001) were confirmed.
- High detection rates highlight the effectiveness of the screening program.
Conclusions:
- The Zhejiang NBS program successfully screened millions of newborns over 11 years.
- Early diagnosis and treatment were provided to over 2,000 infants with CH and PKU.
- The program plays a vital role in preventing severe developmental outcomes.
More Related Videos
04:39A Modified QuEChERS-HPLC Method for Detection of Polycyclic Aromatic Hydrocarbons in Zebrafish Embryos Exposed to Fine Particulate Matter
Published on: June 13, 2025
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022